Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- Pepeto crossed $8.37 million in presale capital with a working exchange entering final testing while the majority of crypto launches this year are...
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- Pepeto confirmed today that its presale crossed $8.37 million, and offers high APY Staking advantage, while the bitcoin price reclaimed $71,000 and on...
-
Toronto, ON, March 25, 2026 (GLOBE NEWSWIRE) -- Inflation is one of the most critical, and often misunderstood, variables in financial planning. In its latest educational post, Cardinal Point Wealth...
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- The Ethereum based crypto Pepeto team announced a major advancement on the AI tools powering the exchange, confirming that infrastructure is being...
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- Pepeto closed its latest stage and the Ethereum based crypto has now reached every major crypto community following a bridge upgrade that removes gas...
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- The new crypto Pepeto just announced that the current presale stage is nearing sell out after opening only 10 hours ago. Demand spiked even higher...
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- The Ethereum based crypto Pepeto confirmed in the latest crypto news that development entered its final window before launch, and the presale responded...
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- The Ethereum based crypto Pepeto’s team just completed its order book engine and multi chain liquidity layer, clearing the last technical milestone...
-
Dubai, UAE, March 25, 2026 (GLOBE NEWSWIRE) -- Pepeto crossed $8.36 million in presale and the indicators are identical to what appeared right before Dogecoin created a wave of millionaires. Rounds...
-
SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal...